Leqembi and Aduhelm, which were jointly developed by Japan's Eisai and Biogen of US "represent an important advancement in the ongoing fight to effectively treat Alzheimer's disease," says Food and Drug Administration.
A new study on Alzheimer's disease says that there is a way of screening people for early intervention and it all lies in the way we use words when we speak.
A small trial in humans has yielded positive results whereby the new drug safely turned off the production of a protein which can clump into dangerous plaques in the brain, resulting in irreversible neurodegeneration.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2023 TRT World.
Like
Follow